Posts

Posted on

ACI Worldwide Powers Rabobank’s Wero Instant Payments, Advancing Europe’s Real-Time Payments Transformation

ACI Worldwide Powers Rabobank’s Wero Instant Payments, Advancing Europe’s Real-Time Payments Transformation

Shift marks a critical step in one of Europe’s largest payment transformations, turning a national payment system into a pan-European, real-time digital solution

OMAHA, Neb.–(BUSINESS WIRE)–ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, today announced that Rabobank, a leading Dutch bank and one of Europe’s largest financial institutions, is advancing the migration of the Netherlands’ most widely used payment method, iDEAL, to Wero. Wero is the European Payments Initiative (EPI)-backed digital payment solution enabling real-time account-to-account payments across participating European banks.

Rabobank’s Wero payments are processed and powered by ACI’s Real-Time Payments Processing technology, delivering the scale, resilience and interoperability required for pan-European instant payments. The ACI platform provides the high availability needed for this transformational project. By orchestrating payment flows, liquidity management and real-time clearing across SEPA Instant rails, ACI is helping Rabobank seamlessly transition iDEAL into a true real-time environment while ensuring consistent performance, security and regulatory compliance as volumes accelerate.

iDEAL is the backbone of Dutch digital commerce, used for more than 70% of online transactions and billions of payments each year. While it provides consumers and merchants with instant confirmation at checkout, the underlying payments have traditionally been processed on standard SEPA Credit Transfer (SCT) rails. Rabobank is now changing that, moving iDEAL volumes onto SEPA Instant Credit Transfer (SCT Inst) infrastructure powered by ACI, enabling true real-time, 24/7 clearing and settlement.

As one of the founding banks behind iDEAL, Rabobank plays a central role in scaling this transition, effectively moving a large share of everyday payments in the Netherlands onto instant payment rails. The migration is expected to complete by the end of 2027. Rabobank, alongside other EPI shareholders, committed to the transition as part of the European Payments Initiative (EPI), which aims to unify fragmented national payment schemes into a single European solution and reduce reliance on global card networks.

This shift marks a critical step in one of Europe’s largest payment transformations, turning a national payment system into a pan-European, real-time digital solution. Through Wero, consumers and businesses will be able to make instant account-to-account payments not only online, but also in-store and between individuals, across borders.

In parallel, Rabobank is extending instant payments capabilities beyond checkout by routing Request to Pay messaging through Wero. This enables a broader set of instant payment use cases, from bill payments to subscriptions and merchant-initiated transactions, where speed, certainty, and immediate fund availability are critical.

“Wero represents the next evolution of how people pay in Europe, bringing together the trust and ubiquity of iDEAL with instant, pan-European capabilities,” said Patrick Kipping, area lead, payments transaction processing, Rabobank. “Migrating iDEAL at this scale is a significant operational step, and an important milestone in delivering instant, seamless payments for our customers.”

The transition comes as Europe enters a new phase of real-time payments adoption. With the Instant Payment Regulation (IPR) now in force, banks are turning their focus to scaling performance, resilience and instant payments processing at national volumes.

“Rabobank is moving one of Europe’s most successful national payment systems into a true instant payments environment, at scale,” said Craig Ramsey, global head of account-to-account Payments, ACI Worldwide. “This is exactly what the shift to instant payments is about: not just faster payments but transforming how entire economies move money. ACI’s platform is designed to manage that level of volume, resilience, and complexity.”

The Netherlands is the first major market to transition their successful, local iDEAL payments solution to Wero, positioning it at the forefront of Europe’s shift toward instant, account-to-account payments. The speed and stability of this migration will help set the benchmark for Wero’s broader rollout across Europe through 2027.

About ACI Worldwide

ACI Worldwide, an original innovator in global payments technology, delivers transformative software solutions that power intelligent payments orchestration in real time so banks, billers and merchants can drive growth, while continuously modernizing their payment infrastructures, simply and securely. With nearly 50 years of trusted payments expertise, we combine our global footprint with a local presence to offer enhanced payment experiences to stay ahead of constantly changing payment challenges and opportunities.

© Copyright ACI Worldwide, Inc. 2026

ACI, ACI Worldwide, ACI Payments, Inc., ACI Pay, Speedpay, and all ACI product/solution names are trademarks or registered trademarks of ACI Worldwide, Inc., or one of its subsidiaries, in the United States, other countries, or both. Other parties’ trademarks referenced are the property of their respective owners.

Media

Katrin Boettger | Communications and Corporate Affairs Director | [email protected]

Pierce Rohrmann I Head of Communications and Corporate Affairs I [email protected]

KEYWORDS: Europe United States Netherlands North America Nebraska

INDUSTRY KEYWORDS: Technology Payments Finance Consulting Fintech Banking Electronic Commerce Professional Services Networks

MEDIA:

Logo
Logo
Posted on

Teledyne FLIR Defense Unveils Three Vehicle Vision Systems for Enhanced Battlefield Awareness

Teledyne FLIR Defense Unveils Three Vehicle Vision Systems for Enhanced Battlefield Awareness

Next-generation systems support targeting, driver vision, and visibility in challenging conditions for both manned and unmanned military vehicles

Scalable imaging solutions designed to augment crew safety and mission effectiveness in dynamic environments

PARIS–(BUSINESS WIRE)–
Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), today announced at Eurosatory the launch of three upgraded vision systems for military vehicles that enhance targeting, improve driver vision, and expand field-of-view up to 360 degrees. The newly launched solutions include the ThermoVision® Situational Awareness HD (SA90-HD) and ThermoVision® Driver Vision HD (DV55-HD) Vehicle Vision Systems, and the MilSight® LIRC III Compact Vehicle-Mounted Weapon Sight.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615122823/en/

Teledyne FLIR Defense announced at Eurosatory the launch of three upgraded vision systems for military vehicles that enhance targeting, improve driver vision, and expand field-of-view up to 360 degrees. The newly launched solutions include the ThermoVision® Situational Awareness HD (SA90-HD) and ThermoVision® Driver Vision HD (DV55-HD) Vehicle Vision Systems, and the MilSight® LIRC III Compact Vehicle-Mounted Weapon Sight.

Teledyne FLIR Defense announced at Eurosatory the launch of three upgraded vision systems for military vehicles that enhance targeting, improve driver vision, and expand field-of-view up to 360 degrees. The newly launched solutions include the ThermoVision® Situational Awareness HD (SA90-HD) and ThermoVision® Driver Vision HD (DV55-HD) Vehicle Vision Systems, and the MilSight® LIRC III Compact Vehicle-Mounted Weapon Sight.

These latest upgrades to FLIR Defense’s mission-tested and battle-ready systems significantly improve object detection and identification in all terrains and conditions, delivering full visibility even through smoke and fog, day or night. Compact and easy to integrate, each system features a lightweight, small form factor and single cable setup. Together, all three vehicle vision systems can be scaled to meet multiple requirements and provide up to 360-degree awareness on one vehicle. Deployed individually or in combination, the solutions support a range of mission needs, including target acquisition, situational awareness, obstacle avoidance, and threat detection and identification.

“As battlefield hazards evolve, visibility in complex environments is critical to warfighter safety and success,” said Nicklas Friberg, Vice President of Surveillance Systems at Teledyne FLIR Defense. “Our newly upgraded vehicle vision systems give operators an advantage against faster, smaller, and more complex threats with some of the industry’s first integrated HD solutions designed specifically for military vehicle platforms.

“By leveraging advanced visual/thermal imaging technology with flexible, more complete coverage, crewed vehicle missions can become safer for operators, while unmanned missions become more effective,” Friberg added.

ThermoVision Situational Awareness (SA90-HD) is designed to be mounted around the vehicle for comprehensive 360-degree situational awareness through fog, smoke, and low-light conditions, while ThermoVision Driver Vision (DV55-HD) is a forward-facing camera optimized for driving and maneuvering. Both represent rugged and compact Electro-Optical and Infrared (EO/IR) imaging systems that blend thermal and color camera imaging for improved feature recognition, essential to target detection and identification in all conditions. Dual 1280p EO/IR sensors deliver crisp detail, which can be blended to reveal key details that are essential to the mission.

MilSight LIRC IIIis a compact, vehicle-mounted thermal imager integrated with the vehicle gunner’s sight, ideal for armored vehicles and long-range target acquisition applications. Enhanced digital imaging provides crisp imagery regardless of scene dynamics, and seamless autofocus maintains sharp and clear images without constant user input.

FLIR Defense provides advanced vehicle visions systems to customers in nearly 20 countries, with over 3,500 systems currently deployed.

All three of the upgraded Vehicle Vision Systems are designed and built by Teledyne FLIR Defense at its facilities in Täby, Sweden, and are now available for customer orders. Visit Teledyne FLIR Defense at Eurosatory in Hall 5A, Stand A129 or learn more online.

About Teledyne FLIR Defense

Teledyne FLIR Defense has been providing advanced, mission-critical technology and systems for more than 45 years. Our products are on the frontlines of the world’s most pressing military, security and public safety challenges. As a global leader in thermal imaging, we design and build sophisticated surveillance sensors for air, land and maritime use. We develop the most rugged, trusted unmanned air and ground platforms, as well as intelligent sensing devices used to detect chemicals, biological agents, radiation and explosives. At Teledyne FLIR Defense we bring together this expertise to deliver solutions that enable critical decisions and keep our world safe – from any threat, anywhere. To learn more, visit us online or follow @flir and @flir_defense.

About Teledyne Technologies

Teledyne Technologies is a leading provider of sophisticated digital imaging products and software, instrumentation, aerospace and defense electronics, and engineered systems. Teledyne’s operations are primarily located in the United States, the United Kingdom, Canada, and Western and Northern Europe. For more information, visit Teledyne’s website at www.teledyne.com.

Media Contacts:

Joe Ailinger, Jr.

Teledyne Defense & Aerospace

Email: [email protected]

Tabitha Blankenbiller

Teledyne Defense & Aerospace

Email: [email protected]

KEYWORDS: France Europe

INDUSTRY KEYWORDS: Automotive Manufacturing Government Technology Security Manufacturing Defense Audio/Video Autonomous Driving/Vehicles Automotive Other Technology State/Local Other Defense EV/Electric Vehicles Artificial Intelligence Software Technology Public Policy/Government Law Enforcement/Emergency Services Military Engineering

MEDIA:

Photo
Photo
Teledyne FLIR Defense announced at Eurosatory the launch of three upgraded vision systems for military vehicles that enhance targeting, improve driver vision, and expand field-of-view up to 360 degrees. The newly launched solutions include the ThermoVision® Situational Awareness HD (SA90-HD) and ThermoVision® Driver Vision HD (DV55-HD) Vehicle Vision Systems, and the MilSight® LIRC III Compact Vehicle-Mounted Weapon Sight.
Logo
Logo
Posted on

Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

Concurrent with the Offering, Alvotech has entered into Subscription Agreement(s) with certain investors that are professional clients or eligible counterparties in the European Economic Area falling within article 1(4) of Regulation (EU) 2017/1129, pursuant to which Alvotech will issue and sell 17,826,666 ordinary shares to such investors at a price of $3.75 per ordinary share, which represents the per share public offering price, in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. The gross proceeds from the concurrent private placement, before deducting any transaction-related expenses, are expected to be approximately $67 million. The concurrent private placement is expected to close on or about June 25, 2026, subject to the consummation of the Offering and other customary conditions. However, the consummation of the Offering is not contingent on the consummation of the concurrent private placement.

The total gross proceeds from the Offering and the concurrent private placement are expected to be approximately $152 million, or approximately $165 million if the underwriters exercise in full their option to purchase additional shares, in each case before deducting underwriting discounts and commissions and estimated offering expenses payable.

Alvotech intends to use the net proceeds from this Offering and the concurrent private placement to fund the continued development of its biosimilar assets, as well as working capital and general corporate purposes, which may include, among others, intellectual property protection and enforcement, commercial expenditures, capital expenditures, acquisitions or collaborations, pre-clinical and clinical development of its product candidates, research and development and product development, pre-commercialization activities and repayment or refinancing of indebtedness or other corporate borrowings.

BofA Securities, Jefferies and Evercore ISI are acting as joint book-running managers for the Offering.

The Offering is being made pursuant to a registration statement on Form F-3, including a base prospectus, that was previously filed with the U.S. Securities and Exchange Commission (“SEC”) on October 20, 2023, and declared effective on October 30, 2023. The ordinary shares referred to in this press release are being offered in the United States only by means of a prospectus supplement and the accompanying prospectus that forms a part of the registration statement. Copies of the final prospectus supplement and the accompanying prospectus related to this Offering may be obtained, when available, from: BofA Securities, Attention: Prospectus Department, 201 North Tryon Street, Charlotte, NC 28255-0001, or by email at [email protected]; Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at (877) 821-7388, or by email at [email protected]; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, NY 10055, by telephone at (888) 474-0200, or by email at [email protected]. Investors may also obtain these documents at no cost by visiting the SEC’s website at http://www.sec.gov.

About Alvotech

Alvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in biosimilars by delivering high-quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Five biosimilars are already approved and marketed in multiple global markets, including biosimilars to Humira® (adalimumab), Stelara® (ustekinumab), Simponi® (golimumab), Eylea® (aflibercept) and Prolia®/Xgeva® (denosumab). The current development pipeline includes nine disclosed biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East.

Important information

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these shares, nor shall there be any sale of these shares, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The distribution of this document may, in certain jurisdictions, be restricted by local legislations. Persons into whose possession this document comes are required to inform themselves about and to observe any such potential local restrictions.

This press release is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017 on the prospectus to be published when shares are offered to the public admitted to trading on a regulated market, as amended (the “Prospectus Regulation”) and has not been approved by any regulatory authority in any jurisdiction. The Company has not authorized any offer to the public of shares or other securities in any member state of the EEA and no prospectus has been or will be prepared in connection with the Offering. In any EEA Member State, this communication is only addressed to and is only directed at “qualified investors” in that Member State within the meaning of the Prospectus Regulation.

With respect to the member States of the European Economic Area (a “Relevant Member State”), no action has been undertaken or will be undertaken to make an offer to the public of the shares referred to herein requiring a publication of a prospectus in any Relevant Member State. As a result, the shares may not and will not be offered in any Relevant Member State except in accordance with the exemptions set forth in Article 1(4) of the Prospectus Regulation or under any other circumstances which do not require the publication by the Company of a prospectus pursuant to Article 3 of the Prospectus Regulation and/or to applicable regulations of that Relevant Member State.

In addition, in the United Kingdom, this announcement is directed at and for distribution only to Qualified Investors who are (i) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005, as amended (the “Order”), or (ii) persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, and (iii) other persons to whom this announcement may otherwise lawfully be communicated (all such persons together being referred to as “Relevant Persons”). The shares referred to herein are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such shares will be engaged in only with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this communication or any of its contents.

No announcement or information regarding this Offering may be disseminated to the public in jurisdictions where a prior registration or approval is required for such purpose. Other than the registration statement filed with the SEC, no steps have been taken, or will be taken, for the Offering of shares in any jurisdiction where such steps would be required. The issue or sale of shares, and the subscription for or purchase of shares, are subject to special legal or statutory restrictions in certain jurisdictions. This press release contains inside information within the meaning of MAR that Alvotech is legally obliged to publish. The information was released for publication, through the agency of the contact persons below, at the date and time indicated by the dateline of publication.

Forward Looking Statements

Certain statements in this communication may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include, but are not limited to, Alvotech’s expectations regarding the completion and timing of the Offering and the concurrent private placement, the potential exercise of the underwriters’ option to purchase additional shares, and the expected use of proceeds. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential”, “aim” or “continue”, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Alvotech and its management, are inherently uncertain and are inherently subject to risks, variability, and contingencies, many of which are beyond Alvotech’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: whether or not we will be able to consummate the Offering the final terms of the offering, the satisfaction of customary conditions precedent to close the proposed Offering and concurrent private placement, and other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in documents that Alvotech may from time to time file or furnish with the SEC, including the final prospectus supplement and the accompanying prospectus related to this Offering and the Company’s most recent annual report on Form 20-F. There may be additional risks that Alvotech does not presently know or that Alvotech currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as a representation, guarantee, assurance, prediction or definitive statement of a fact or probability. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred to in this communication.

Media

Benedikt Stefansson
Sarah MacLeod
[email protected]

Investors

Dr. Balaji V Prasad
Benedikt Stefansson
[email protected]



Posted on

PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes

PR Newswire

– Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 convertible notes prior to or at maturity –

– Offering made at 0% interest with conversion price of $107.48, a 40% premium over the closing price on June 15, 2026 –

WARREN, N.J., June 15, 2026 /PRNewswire/ — PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced the pricing of $500.0 million aggregate principal amount of 0% Convertible Senior Notes due 2031 (the “Notes”) in a private placement (the “Offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). PTC also granted the initial purchasers an option to purchase, within the 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $50.0 million aggregate principal amount of Notes from PTC. The sale of the Notes is expected to close on June 18, 2026, subject to the satisfaction of customary closing conditions.

The Notes will be general senior unsecured obligations of PTC, and will not bear regular interest and the principal amount of the Notes will not accrete. The Notes will mature on June 15, 2031, unless earlier converted, repurchased or redeemed.

PTC estimates that the net proceeds from the Offering will be approximately $486.8 million (or approximately $535.5 million if the initial purchasers exercise their option to purchase additional Notes in full), after deducting the initial purchasers’ discounts and commissions and estimated offering expenses payable by PTC.

PTC expects to use approximately $328.8 million of the net proceeds from the Offering to repurchase for cash $222.0 million in aggregate principal amount of its 1.5% Convertible Senior Notes due 2026 (the “2026 Notes”) pursuant to the concurrent note repurchase transactions described below. Given the dynamics of the Offering, PTC will not use any proceeds of the Offering to repurchase, concurrently with the Offering, shares of its common stock sold short by initial investors in the Offering. The remaining net proceeds from the Offering will be used for general corporate purposes, which may include additional repurchases of the 2026 Notes from time to time following the Offering and the repayment or retirement of any remaining 2026 Notes at maturity.

Prior to the close of business on the business day immediately preceding March 15, 2031, holders will have the right to convert their Notes only upon the satisfaction of specified conditions and during certain periods. On or after March 15, 2031 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes at any time. Upon conversion, PTC will pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at its election.

The conversion rate for the Notes will initially be 9.3042 shares of PTC’s common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $107.48 per share of PTC’s common stock). The initial conversion price represents a premium of approximately 40% over the closing price of $76.77 per share of PTC’s common stock on the Nasdaq Global Select Market on June 15, 2026.

PTC may not redeem the Notes prior to June 20, 2029. On or after June 20, 2029, PTC may redeem for cash all or any portion of the Notes, at its option, if the last reported sale price of PTC’s common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which PTC provides written notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid special interest, if any, to, but excluding, the redemption date. No sinking fund is provided for the Notes, which means PTC is not required to redeem or retire the Notes periodically.

If PTC undergoes a “fundamental change” (as defined in the indenture that will govern the Notes), then, subject to certain conditions and limited exceptions, holders may require PTC to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid special interest, if any, to, but excluding, the fundamental change repurchase date. In addition, following certain corporate events that occur prior to the maturity date or if PTC delivers a notice of redemption, PTC will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with such a corporate event or notice of redemption, as the case may be.

Concurrently with the pricing of the Notes in the Offering, PTC entered into private negotiated transactions with certain holders of the 2026 Notes to repurchase for a total repurchase cost (including accrued and unpaid interest) of approximately $328.8 million in cash $222.0 million in aggregate principal amount of the 2026 Notes on terms negotiated with each holder. This press release is not a notice of redemption or an offer to repurchase the 2026 Notes, and the Offering of the Notes is not contingent upon the repurchase of any of the 2026 Notes.

In connection with any repurchase of the 2026 Notes, PTC expects that holders of the 2026 Notes who agreed to have their 2026 Notes repurchased may enter into or unwind various derivatives with respect to PTC’s common stock and/or purchase shares of PTC’s common stock concurrently with or shortly after the pricing of the 2026 Notes. In particular, PTC expects that certain holders of the 2026 Notes employ a convertible arbitrage strategy with respect to the 2026 Notes and have a short position with respect to PTC’s common stock that they will close out through purchases of PTC’s common stock and/or the unwinding of various derivatives with respect to PTC’s common stock, as the case may be, in connection with PTC’s repurchase of the 2026 Notes. This activity could increase (or reduce the size of any decrease in) the market price of PTC’s common stock, which may also affect the trading price of the Notes at that time. This activity may have affected the market price of PTC’s common stock prior to, concurrently with or shortly after the pricing of the Notes, and could result in a higher effective conversion price of the Notes. PTC cannot predict the magnitude of such market activity or the overall effect it will have on the price of the Notes or PTC’s common stock.

The Notes were only offered by means of a private offering memorandum. The offer and sale of the Notes and any shares of PTC’s common stock issuable upon conversion of the Notes have not been, and will not be, registered under the Securities Act or any other securities laws, and the Notes and any such shares cannot be offered or sold except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any other applicable securities laws.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, the Notes or any shares of PTC’s common stock issuable upon conversion of the Notes, nor will there be any sale of the Notes or any such shares, in any state or other jurisdiction in which such offer, sale or solicitation would be unlawful. 

About PTC Therapeutics, Inc. 
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company’s strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders.

For more information please contact:

Investors:
Ellen Cavaleri
+1 (615) 618-8228
[email protected]

Media:
Jeanine Clemente
+1 (908) 912-9406
[email protected]

Cautionary Note Regarding Forward-Looking Statements:

The press release contains information about future expectations, plans and prospects of PTC’s management that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995, including statements with respect to PTC’s expectations to complete the Offering of the Notes, its use of proceeds from the Offering and the effect of the concurrent note repurchase. There can be no assurance that PTC will be able to complete the notes offering on the anticipated terms, or at all. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, the terms of the Notes and the Offering, risks and uncertainties related to whether or not PTC will consummate the Offering, the impact of general economic, industry, market or political conditions and other factors that are discussed in PTC’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other documents periodically filed with the Securities and Exchange Commission.

In addition, the statements in this press release represent PTC’s expectations and beliefs as of the date of this press release. PTC anticipates that subsequent events and developments may cause these expectations and beliefs to change. However, while PTC may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing PTC’s expectations or beliefs as of any date subsequent to the date of this press release.

Cision View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-pricing-of-convertible-notes-offering-to-refinance-2026-convertible-notes-302801013.html

SOURCE PTC Therapeutics, Inc.

Posted on

Ingram Micro Named 2026 Global Distributor of the Year by HPE

Ingram Micro Named 2026 Global Distributor of the Year by HPE

A third global HPE Distributor of the Year win is followed by several regional annual wins for Ingram Micro, including Australia, Brazil, Chile, Turkey and UKIMEA

LAS VEGAS–(BUSINESS WIRE)–HPE DISCOVER–Ingram Micro Holding Corporation (NYSE: INGM) has once again earned the title of HPE’s Global Distributor of the Year.

The 2026 win, which was presented to Ingram Micro’s CEO Paul Bay at the HPE Partner Growth Summit 2026 in Las Vegas, NV, recognized the global team’s commitment to delivering value to HPE partners who are helping businesses of all sizes achieve their growth ambitions. The award reflects Ingram Micro’s exceptional performance in delivering high-value, high-growth programs and creating innovative solutions that help deliver significant business outcomes as a distribution partner and B2B Platform business.

“Our customer-first mindset is what drives Ingram Micro’s performance and makes the partnerships we establish and grow so valuable,” said Bay. “HPE has been a tremendous partner for many years, and we are looking forward to what we can do together this year.”

In addition to winning the 2026 HPE Global Distributor of the Year award, Ingram Micro’s regional and local teams were recognized with several other accolades:

  • Australia: HPE Distributor of the Year 2026
  • Brazil: HPE Distributor of the Year 2026 and HPE Value Distributor of the Year 2026
  • Chile: HPE Distributor of the Year 2026
  • Turkey: HPE Distributor of the Year 2026 and HPE Networking Distributor of the Year 2026
  • UK + Ireland + Middle East + Africa (UKIMEA): HPE Distributor of the Year 2026

Key capabilities and results underpinning Ingram Micro’s repeat wins include aligned, focused execution against HPE’s strategic priorities and shared growth goals; continued strategic investment in Hybrid Cloud, AI, Networking, and GreenLake solutions; and support for business customers to develop new capabilities, grow their revenues, and increase profit opportunities.

“The HPE Partner of the Year 2026 Awards spotlight partners who don’t just keep pace with innovation, they invest in truly understanding the full HPE portfolio and building the expertise to apply it to real customer challenges,” said Simon Ewington, senior vice president of Worldwide Channel and Partner Ecosystem at HPE. “That depth of capability is what turns great technology into measurable outcomes for our customers. HPE is proud to celebrate our partners’ achievements and to help them deliver world-class innovation and services for all our customers.”

Earning the top distribution award follows Ingram Micro being selected as one of two HPE Global Distributors, which includes full access to HPE’s entire portfolio–including HPE networking, cloud, and AI solutions. The new and expanded Ingram Micro, HPE engagement will introduce enhanced services, solutions, and support through the Ingram Micro HPE Partner Growth Accelerator Program, as well as a broader geographic reach for partners and customers worldwide.

“We are honored to be recognized by HPE as their Global Distributor of the Year and earning additional accolades for our local teams. Earning this award three times is a testament to the commitment we make with our HPE relationship and the value we place on generating growth together,” said Eric Kohl, Vice President, Global Vendor Engagement, Security & Networking, Ingram Micro. “Our longstanding and growing collaboration with HPE is built on trust, execution, and a strong, shared commitment to helping our mutual channel partners realize their growth potential by delivering innovative solutions and services and enabling true business outcomes for end customers.”

More information can be found here.

About HPE

HPE (NYSE: HPE) is a leader in essential enterprise technology, bringing together the power of AI, cloud, and networking to help organizations achieve more. As pioneers of possibility, our innovation and expertise advance the way people live and work. We empower our customers across industries to optimize operational performance, transform data into foresight, and maximize their impact. Unlock your boldest ambitions with HPE. Discover more at  www.hpe.com.

About Ingram Micro

Ingram Micro (NYSE: INGM) is a leading technology company in the global information technology ecosystem. With the ability to reach nearly 90% of the global population, we play a vital role in the worldwide IT sales channel, bringing products and services from technology manufacturers and cloud providers to a highly diversified base of business-to-business technology experts. Through Ingram Micro Xvantage™, our AI-powered digital platform, we offer what we believe to be the industry’s first comprehensive business-to-consumer-like experience, integrating hardware and cloud subscriptions, personalized recommendations, instant pricing, order tracking, and billing automation. We also provide a broad range of technology services, including financing, specialized marketing, and lifecycle management, as well as technical pre- and post-sales professional support. Learn more at www.ingrammicro.com.

Media Contact:
Marie Meoli Rourke
714-292-2199
[email protected]

KEYWORDS: Ireland Latin America Australia Brazil Australia/Oceania United States South America United Kingdom North America Middle East Africa Europe Chile Turkey California Nevada

INDUSTRY KEYWORDS: Technology Security Other Technology Telecommunications Software Artificial Intelligence Networks Internet VoIP Mobile/Wireless Hardware

MEDIA:

Logo
Logo
Posted on

Oak-Eagle AcquireCo, Inc. Announces Extension of the Expiration Time and Settlement Date for the Previously Announced Tender Offers and Consent Solicitations for Any and All of Electronic Arts Inc.’s 1.850% Senior Notes Due 2031 and 2.950% Senior Notes Due 2051

PR Newswire

WILMINGTON, Del., June 15, 2026 /PRNewswire/ — Oak-Eagle AcquireCo, Inc. (the “Offeror”) announced today the extension of the Expiration Time and Settlement Date for the previously announced offers to purchase for cash (each, a “Tender Offer” and, together, the “Tender Offers”) any and all of Electronic Arts Inc.’s (NASDAQ: EA) (the “Company”) outstanding (i) 1.850% Senior Notes due 2031 (the “2031 Notes”) and (ii) 2.950% Senior Notes due 2051 (the “2051 Notes” and, together with the 2031 Notes, the “Notes”), and solicitations of consents (each, a “Consent Solicitation” and, together, the “Consent Solicitations”) from holders of the Notes (each, a “Holder” and, collectively, the “Holders”) to certain proposed amendments (the “Proposed Amendments”) to the indenture, dated as of February 24, 2016, as supplemented by that certain Second Supplemental Indenture, dated as of February 11, 2021, by and between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “Trustee”) (the “Indenture”) (such consents being solicited are each a “Consent” and, collectively, the “Consents”).

The previously announced Expiration Time of 5:00 P.M., New York City time, on June 15, 2026, has been extended with respect to all Holders to 5:00 P.M., New York City time, on July 15, 2026, unless extended or earlier terminated, and the Settlement Date has been extended to July 20, 2026, unless extended or earlier terminated. The Offeror intends to extend the Expiration Time, without extending the Withdrawal Deadline (unless required by law), such that it will remain within three business days prior to the Settlement Date, which we anticipate will occur on or about the closing date of the Merger. The Withdrawal Deadline of 5:00 P.M., New York City time, on February 24, 2026 (the “Withdrawal Deadline”), is not extended and has already expired and any Notes tendered after the Withdrawal Deadline may not be withdrawn.

The Tender Offers and the Consent Solicitations are being made in connection with, and are expressly conditioned upon the closing of, the acquisition of the Company pursuant to the Agreement and Plan ‎of Merger, dated September 28, 2025 (as it may be amended, supplemented or modified from time to ‎time, the “Merger Agreement”), by and among the Company, the Offeror and Oak-Eagle MergerCo, Inc., a Delaware corporation and a wholly-owned subsidiary of the Offeror (“Merger Sub”), pursuant to which Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly-owned subsidiary of the Offeror, in each case on and subject to the terms and conditions therein. The Offeror and Merger Sub were formed by an investor consortium consisting of The Public Investment Fund, Silver Lake and Affinity Partners, for purposes of engaging in the transactions contemplated by the Merger Agreement. The consummation of the Merger is not conditioned on the consummation of the Tender Offers and the Consent Solicitations.

The terms and conditions of the Tender Offers and Consent Solicitations are described in the Offer to Purchase and Consent Solicitation Statement relating to the Notes dated as of February 10, 2026 (as amended or supplemented from time to time, the “Offer to Purchase and Consent Solicitation Statement”). Capitalized terms used herein, but not otherwise defined, have the meanings ascribed to such terms in the Offer to Purchase and Consent Solicitation Statement.

The table below outlines the approximate principal amount of the Notes validly tendered and not validly withdrawn as of the date hereof, according to information provided by Global Bondholder Services Corporation, the depositary and information agent for the Tender Offers and the Consent Solicitations (the “Depositary and Information Agent”). Any Notes validly tendered after February 24, 2026, but on or prior to the Expiration Time, will be eligible to receive the Tender Offer Consideration set forth in the table below. The Offeror currently intends to accept all Notes tendered in the Tender Offers, subject to the satisfaction of the conditions described below.


Title of Notes


CUSIP/ISIN

(1)


Outstanding
Principal
Amount


Reference
Security


Reference
Yield


Fixed
Spread
(bps)


Tender Offer
Consideration

(2) (3)


Aggregate
Principal
Amount
Tendered

1.850% Senior
Notes due 2031

CUSIP:
285512AE9

ISIN:
US285512AE93

$750,000,000

3.750%
UST due
January 31,
2031

3.626 %

+0

$875.82

$68,586,000

2.950% Senior
Notes due 2051

CUSIP:
285512AF6

ISIN:
US285512AF68

$750,000,000

4.625%
UST due
November
15, 2055

4.705 %

+0

$695.96

$7,917,000

(1) The CUSIP numbers and ISINs referenced in this press release are included solely for the convenience of Holders.  None of the Offeror, the Company, the Trustee, the Dealer Manager (as defined below), the Depositary and Information Agent nor their respective affiliates shall be held responsible for the selection or use of the referenced CUSIP numbers and ISINs, and no representation is made as to the correctness of any CUSIP number or ISIN on the Notes or as indicated in this press release or any other document.
(2) As defined in the Offer to Purchase and Consent Solicitation Statement. Calculated based on the Settlement Date of July 20, 2026. Subject to update pursuant to the Offer to Purchase and Consent Solicitation if the Tender Offers settle on a different date.
(3) Per $1,000 principal amount of Notes validly tendered and not validly withdrawn after February 24, 2026, but on or prior to the Expiration Time.

General Information

The Offeror’s obligations to complete each Tender Offer and Consent Solicitation are subject to and conditioned upon the following having occurred or, in the case of the General Conditions, having been waived by the Offeror with respect to such Tender Offer and Consent Solicitation, as applicable: (1) the satisfaction of the Merger Condition, and (2) the satisfaction of the General Conditions. Each Tender Offer and Consent Solicitation is a separate offer and is not conditioned on any other Tender Offer or Consent Solicitation. There can be no assurance that any of the Tender Offers or the Consent Solicitations will be consummated. The Offeror may amend, extend or terminate the Tender Offers and the Consent Solicitations, in its sole discretion.

The Offeror intends to fund the Total Consideration (including accrued and unpaid interest), plus all related fees and expenses, using proceeds from the financing transactions to fund the Merger. Notes that are tendered and accepted in the Tender Offers will cease to be outstanding and will be cancelled.

Any Notes not tendered and purchased pursuant to the Tender Offers will remain outstanding. If the requisite Consents are received with respect to a series of Notes, and the Proposed Amendments become operative with respect to the Indenture for such series of Notes, then the applicable Notes that are not purchased pursuant to the Tender Offers will be subject to the Proposed Amendments. The Proposed Amendments would amend the Indenture to eliminate certain restrictive covenants, eliminate certain events of default and modify or eliminate certain other provisions with respect to such series of Notes. The Requisite Consents have not yet been received with respect to either series of Notes.

To the extent any Notes remain outstanding following the consummation of the Tender Offers and the Consent Solicitations, the Offeror currently intends to cause the Company to defease one or both series of Notes, in which case Holders of such Notes will continue to receive interest on each scheduled interest payment date and principal on the stated maturity date but will not benefit from any restrictive covenants removed pursuant to the defeasance, including the change of control repurchase obligations. The Proposed Amendments do not need to be adopted in order to defease one or both series of Notes in accordance with the terms of the Indenture. To the extent any Notes remain outstanding following the consummation of the Tender Offers and the Consent Solicitations, the Company may (or the Offeror may cause the Company to) also purchase, repurchase, redeem or otherwise acquire or retire the 2031 Notes and/or the 2051 Notes by any available means, including, without limitation, negotiated transactions, open market purchases, tender offers, redemption or otherwise, upon such terms and at such prices as the Offeror or the Company may determine. Any such transaction may be on the same terms or on terms that are more or less favorable to Holders of Notes than the terms of the Tender Offers and the Consent Solicitations and will depend on various factors existing at that time. Finally, the Company may (or the Offeror may cause the Company to) leave outstanding any Notes that remain outstanding following the consummation of the Tender Offers and the Consent Solicitations or any transaction described in this paragraph.

J.P. Morgan Securities LLC has been retained as the dealer manager in connection with the Tender Offers and as the solicitation agent in connection with the Consent Solicitations (the “Dealer Manager”). In such capacities, it may contact Holders regarding the Tender Offers and the Consent Solicitations and may request brokers, dealers, commercial banks, trust companies and other nominees to forward the Offer to Purchase and Consent Solicitation Statement and related materials to beneficial owners of Notes. Requests for documents may be directed to the Depositary and Information Agent at: +1 (855) 654 2015 or [email protected]. Questions about the Tender Offers and the Consent Solicitations may be directed to J.P. Morgan Securities LLC at (866) 834-4466 or (212) 834-3424.

This press release is for informational purposes only. The Tender Offers and the Consent Solicitations are being made solely by the Offer to Purchase and Consent Solicitation Statement. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful. The Tender Offers and the Consent Solicitations are not being made to Holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Tender Offers or the Consent Solicitations to be made by a licensed broker or dealer, the Tender Offers and the Consent Solicitations will be deemed to be made on behalf of the Offeror by the Dealer Manager, or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.

None of the Offeror, the Company, the Trustee, the Depositary and Information Agent, the Dealer Manager or any of their respective affiliates makes any recommendation as to whether Holders should tender or refrain from tendering their Notes, and no person or entity has been authorized by any of them to make such a recommendation. Holders must make their own decision as to whether to tender Notes and, if so, the principal amount of the Notes to tender.

Forward-Looking Statements

This press release contains or incorporates by reference certain “forward-looking statements” within ‎the meaning of the federal securities laws. All statements other than statements of historical facts are forward-looking statements. In many cases, you can identify forward-looking statements by terms such ‎as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” ‎‎”believe,” “estimate,” “predict,” “potential” or “continue” or other similar words. These forward-looking ‎statements are only predictions. These statements relate to future events and ‎involve known and unknown risks, uncertainties and other important factors that may cause the ‎actual outcomes to materially differ from those expressed or implied by these forward-looking statements. New factors ‎could emerge from time to time and it is not possible for us to predict all such factors. Because forward-looking ‎statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, ‎you should not rely on these forward-looking statements as guarantees of future events. These forward-looking ‎statements speak only as of the date made and are not guarantees of future performance of results, including the closing of the Merger and successful completion of the Tender Offers and the Consent Solicitations. The Offeror expressly ‎disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statement ‎contained or incorporated by reference herein to reflect any change in expectations with regard thereto or any ‎change of events, conditions or circumstances on which any such statement was based, except as required by law.‎

Cision View original content:https://www.prnewswire.com/news-releases/oak-eagle-acquireco-inc-announces-extension-of-the-expiration-time-and-settlement-date-for-the-previously-announced-tender-offers-and-consent-solicitations-for-any-and-all-of-electronic-arts-incs-1-850-senior-notes-due-2031-a-302800988.html

SOURCE Oak-Eagle AcquireCo, Inc.

Posted on

VIA Investors Have Opportunity to Lead Via Transportation, Inc. Securities Lawsuit

PR Newswire

NEW YORK, June 15, 2026 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Via Transportation, Inc. (NYSE: VIA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Via’s initial public offering (the “IPO” or “Offering”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026.

Rosen Law Firm Logo

So what: If you purchased Via common stock pursuant and/or traceable to the IPO you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Via class action, go to https://rosenlegal.com/cases/via-transportation-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the complaint, the Offering Documents used to effectuate Via’s IPO were false and misleading and omitted to state that, at the time of the IPO, Via’s growth had already begun to encounter obstacles because of Via’s declining Platform Annual Run-Rate Revenue and inability to grow in Germany. As these facts emerged after the IPO, Via shares fell sharply. By the commencement of this action, Via’s shares traded as low as $14.52, a decline of nearly 70% from the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Via class action, go to https://rosenlegal.com/cases/via-transportation-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/via-investors-have-opportunity-to-lead-via-transportation-inc-securities-lawsuit-302800789.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

UPDATED: Forward Industries Announces Letter of Intent to Acquire Solana Company (HSDT)

AUSTIN, TX, June 15, 2026 (GLOBE NEWSWIRE) — Forward Industries, Inc. (NASDAQ: FWDI) today confirms that it made a non-binding proposal to the Board of Directors of Solana Company regarding an all-stock business combination. On June 12th, HSDT responded that its board voted to decline Forward’s offer and chose to not engage in further discussion. We are disappointed and surprised that the HSDT board has chosen to reject Forward’s offer without any discussion or communication. We believe that opening up a dialogue is in the best interest of both companies and their respective shareholders.

Why Forward exists

Forward was built to advance Solana and to create value for our shareholders by offering a differentiated public-markets vehicle for exposure to SOL and the growth of the Solana ecosystem. Since launching our treasury strategy in September 2025, we have assembled the largest Solana treasury in the world, staked the majority of our SOL to our high-performance validator infrastructure, launched fwdSOL as a liquid staking token, and begun deploying capital directly into Solana protocols as an investor and liquidity provider. Forward is taking a first principles approach to fulfilling its long-term vision of becoming the Berkshire Hathaway of Solana while simultaneously reaching our short and medium-term goal of compounding SOL per share materially faster than the SOL staking rate and pushing the Solana ecosystem forward as a whole.

Why we approached HSDT

We respect the HSDT team and know we share a common goal of accelerating the growth and adoption of the Solana ecosystem while also creating shareholder value. With that said, we believe the current market environment necessitates cooperation and strategic action to deliver on promises made to our shareholders and to drive that vision forward.

Under our proposal, HSDT stockholders would receive 0.386 newly-issued shares of Forward common stock for each share of HSDT common stock, representing a premium of approximately 10% to HSDT’s closing share price of $1.48 on the day immediately preceding the date of our proposal, or $1.63 per share. We made this proposal because we believe Forward is a strong partner for HSDT and its stockholders, and that the HSDT team can also be complimentary to Forward and our shareholders. Together, our combined scale, expertise in the Solana ecosystem, and combined efforts will allow us to realize and sustain the value embedded in our companies more effectively than HSDT can on a standalone basis. Our proposal is designed to deliver HSDT stockholders a meaningful premium to recent trading levels, alongside continued — and we believe more liquid — exposure to Solana through Forward shares, which are set to join the Russell 2000 and 3000 indices in the coming weeks.

“We have nothing but respect for the HSDT team and what they have built in the Solana ecosystem so far,” said Ryan Navi, Chief Investment Officer of Forward Industries. “We believe that combining our efforts with HSDT’s would be mutually beneficial for both companies, their stockholders, and the broader Solana community. We approached HSDT as partners, in good faith, because we believe our two companies share far more common ground than not. Like us, they made a promise to both their shareholders and the Solana ecosystem, and we believe that a combined company can better deliver on those promises.”

Forward-Looking Statements

Certain statements in these materials constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “intend,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and other words of similar meaning. These forward-looking statements address various matters including statements relating to Forward Industries’ indicative, non-binding proposal to the Solana Company and any potential transaction therefrom. Each forward-looking statement contained in these materials is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, failure to realize the anticipated benefits of the proposed digital asset treasury strategy; changes in business, market, financial, political and regulatory conditions; risks relating to Forward Industries’ operations and business, including the highly volatile nature of the price of Solana and other cryptocurrencies; the risk that the price of Forward Industries’ common stock may be highly correlated to the price of the digital assets that it holds; risks related to increased competition in the industries and markets in which Forward Industries does and will operate (including the applicable digital assets market); risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes, as well as those risks and uncertainties identified in Forward Industries’ filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and Forward Industries undertakes no obligation to update or revise any of these statements.

Media Contact

[email protected]

Investor Relations

Elevate IR
[email protected]



Posted on

UPDATED: Forward Industries Announces Letter of Intent to Acquire SkyAI, Inc. (SKYA)

AUSTIN, TX, June 15, 2026 (GLOBE NEWSWIRE) — Forward Industries, Inc. (NASDAQ: FWDI) today confirms that it made a non-binding proposal to the Board of Directors of SkyAI, Inc. regarding an all-stock business combination under which SKYA stockholders would receive 0.367 newly-issued shares of Forward common stock for each share of SKYA common stock, representing a premium of approximately 20% to SKYA’s closing share price of $1.29 on the day immediately preceding the date of our proposal, or $1.55 per share. SKYA did not respond to the proposal by its expiration at the close of business on Friday, June 12, 2026. We are disappointed and surprised by the lack of response from the SKYA team and strongly believe that engaging in discussions with Forward is in the best interest of both SKYA and its shareholders.

Why Forward exists

Forward was built to advance Solana and to create value for our shareholders by offering a differentiated public-markets vehicle for exposure to SOL and the growth of the Solana ecosystem. Since launching our treasury strategy in September 2025, we have assembled the largest Solana treasury in the world, staked the majority of our SOL to our high-performance validator infrastructure, launched fwdSOL as a liquid staking token, and begun deploying capital directly into Solana protocols as an investor and liquidity provider. Forward is taking a first principles approach to fulfilling its long-term vision of becoming the Berkshire Hathaway of Solana while simultaneously reaching our short and medium-term goal of compounding SOL per share materially faster than the SOL staking rate and pushing the Solana ecosystem forward as a whole.

Why we approached SKYA

SKYA’s recent pivot toward AI appears to represent a significant departure from the Company’s historical strategy at a time when shareholders have already endured substantial value destruction. Despite the strategic shift, the market has continued to assign a deeply discounted valuation to the business, reflecting investor skepticism regarding the ability of the Company’s new direction to generate sustainable growth and shareholder returns as a standalone entity.

We believe a combination with FWDI offers a compelling alternative path forward. FWDI has established itself as a leading institutional Solana treasury platform with a clearly defined capital allocation framework, access to growth capital, and a strategy centered on increasing intrinsic value on a per-share basis. A transaction would provide SKYA shareholders with exposure to a differentiated digital asset treasury model, enhanced liquidity, greater institutional relevance, and participation in a larger, better-capitalized platform positioned to benefit from the continued growth of the Solana ecosystem.

We believe SKYA shareholders deserve the opportunity to be a part of the strategy and vision that they originally underwrote and to do so with a platform that has a proven strategy, stronger market positioning, and a clear roadmap for long-term value creation.

We made this proposal because we believe Forward is a strong partner for SKYA and its shareholders. We believe our capital structure, our scale as the largest Solana treasury, and our access to capital position us to realize and sustain the value embedded in SKYA more effectively than the company can on a standalone basis. Our proposal was designed to deliver SKYA stockholders a meaningful premium to recent trading levels, alongside continued — and we believe more liquid — exposure to Solana through Forward shares, backed by a leadership team with a demonstrated track record of execution and the support of leading operators in the digital asset industry, including Galaxy Digital and Jump Crypto.

Most importantly, we believe this combination would have advanced a mission SKYA and Forward share: accelerating the growth of the Solana ecosystem and creating durable value for the stockholders of both companies, for the builders and developers who power the network, and for the holders of SOL.

“SKYA trades at a significant discount to the net asset value of its treasury and its recent AI pivot has only exacerbated that discount with its shares meaningfully underperforming both SOL and its treasury-company peers since their pivot,” said Ryan Navi, Chief Investment Officer of Forward Industries. “In the current market environment, it can be difficult for subscale treasury companies to perform when high relative fixed operating costs cause meaningfully lower yields and negative cash flows which continue to erode shareholder value. Forward’s scale, strong balance sheet, and access to capital are precisely what a company in SKYA’s position needs to deliver on the vision it originally promised its shareholders.”

Forward-Looking Statements

Certain statements in these materials constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “intend,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and other words of similar meaning. These forward-looking statements address various matters including statements relating to Forward Industries’ indicative, non-binding proposal to SkyAI, Inc. and any potential transaction therefrom. Each forward-looking statement contained in these materials is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, failure to realize the anticipated benefits of the proposed digital asset treasury strategy; changes in business, market, financial, political and regulatory conditions; risks relating to Forward Industries’ operations and business, including the highly volatile nature of the price of Solana and other cryptocurrencies; the risk that the price of Forward Industries’ common stock may be highly correlated to the price of the digital assets that it holds; risks related to increased competition in the industries and markets in which Forward Industries does and will operate (including the applicable digital assets market); risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes, as well as those risks and uncertainties identified in Forward Industries’ filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and Forward Industries undertakes no obligation to update or revise any of these statements.

Media Contact

[email protected]

Investor Relations

Elevate IR
[email protected]



Posted on

Macerich Announces Pricing of Public Offering of Common Stock

SANTA MONICA, Calif., June 15, 2026 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) (the “Company” or “Macerich”) announced today that it has priced an underwritten public offering of 14,000,000 shares of common stock at a price to public of $23.90 per share, all of which are being offered in connection with the forward sale agreements described below.

Goldman Sachs & Co. LLC is serving as the lead bookrunner and representative of the underwriters of the offering. Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, BMO Capital Markets, TD Securities and Scotiabank are also serving as joint bookrunning managers for the offering.

The Company is entering into forward sale agreements with Goldman Sachs & Co. LLC, Deutsche Bank AG, London Branch, JPMorgan Chase Bank, National Association and Morgan Stanley or their affiliates (the “forward purchasers”), with respect to 14,000,000 shares of the Company’s common stock. In connection with the forward sale agreements, the forward purchasers or their affiliates are expected to borrow and sell an aggregate of 14,000,000 shares of the common stock that will be delivered in the offering. Subject to its right to elect cash or net share settlement, which right is subject to certain conditions, the Company intends to deliver, upon physical settlement of such forward sale agreements on one or more dates specified by the Company occurring no later than June 16, 2027 an aggregate of 14,000,000 shares of its common stock to the forward purchasers or their affiliates in exchange for cash proceeds per share equal to the applicable forward sale price at the time of such settlement, subject to certain adjustments as provided in the forward sale agreements.

The Company has granted the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of common stock. If the underwriters exercise such option, the Company expects to enter into additional forward sale agreements with the forward purchasers in respect of the number of shares sold by the forward purchasers or their respective affiliates in connection with the exercise of such option.

The offering is expected to close on June 17, 2026 subject to customary closing conditions.

The Company will not initially receive any proceeds from the sale of shares of its common stock by the forward purchasers or their affiliates in the offering. The Company intends to use the net proceeds, if any, it receives upon the future settlement of the forward sale agreements to fund future acquisition opportunities and for general corporate purposes. Pending such use, the Company may invest the net proceeds in short-term, interest-bearing deposit accounts.

Selling common stock through the forward sale agreements enables the Company to set the price of such shares upon the pricing of the offering (subject to certain adjustments) while delaying the issuance of such shares and the receipt of the net proceeds by the Company until a time closer to the funding requirements described above.

Copies of the prospectus supplement and accompanying prospectus relating to these securities may be obtained, when available, by contacting: Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, nor shall there be any sale of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any such offer or sale will be made only by means of the prospectus supplement and prospectus forming part of the effective registration statement relating to these securities.

About the Company

Macerich (NYSE: MAC) is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich’s portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, D.C. corridor. Developing and managing properties that serve as community cornerstones, Macerich currently owns approximately 41 million square feet of real estate, consisting primarily of interests in 39 retail centers.

Forward-Looking Information

Information set forth in this press release contains “forward-looking statements” (within the meaning of the federal securities laws, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), which reflect the Company’s expectations regarding future events and plans, including, but not limited to, statements regarding the closing of the offering, the underwriters’ option to purchase additional shares of common stock and the Company’s anticipated use of net proceeds from the offering. Generally, the words “expects,” “anticipates,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “scheduled,” “predicts,” “may,” “will,” “should,” “could,” variations of such words and similar expressions identify forward-looking statements. The forward-looking statements are based on information currently available to us and involve a number of known and unknown assumptions, risks, uncertainties and other factors, which may be difficult to predict and beyond the control of the Company, which could cause actual results to differ materially from those contained in the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the Company’s ability to close the offering including that the closing of the aforementioned offering is subject to, among other things, standard closing conditions and customary rights of the underwriters to terminate the underwriting agreement due to any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions; the actual use of proceeds therefrom; and other risks and uncertainties detailed from time to time in the Company’s filings with the Securities and Exchange Commission (the “SEC”), which are available at the SEC’s website at www.sec.gov. The Company disclaims any obligation to publicly update or revise any forward-looking statements contained in this press release whether as a result of changes in underlying assumptions or factors, new information, future events or otherwise, except as required by law.

INVESTOR CONTACT: Investor Relations, [email protected]